A study for a 43 year old man who takes Lipidil, Crestor - from FDA reports


156 males aged 43 (±5) who take the same drugs are studied. This is a personalized study for a 43 year old male patient who has High Cholesterol. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Sep, 25, 2018

156 males aged 43 (±5) who take Lipidil, Crestor are studied.


Number of reports submitted per year:

Lipidil, Crestor for a 43-year old man.

Information of the patient in this study:

  • Age: 43
  • Gender: male
  • Conditions: High Cholesterol
  • Drugs taken:
    • Lipidil (fenofibrate)
    • Crestor (rosuvastatin calcium)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Stable angina (a constant chest pain)
  2. Liver function test abnormal
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Blood creatine phosphokinase increased
1 - 6 months:
  1. Drug eruption (adverse drug reaction of the skin)
  2. Iatrogenic injury (iatrogenic injury is a form of medical error)
  3. Hyperkalemia (damage to or disease of the kidney)
  4. Pneumonia
  5. Pulmonary oedema (fluid accumulation in the lungs)
6 - 12 months:
  1. Muscle aches (muscle pain)
  2. Hyperglycemia (high blood sugar)
  3. Dysstasia (difficulty in standing)
  4. Hypertriglyceridaemia (excess of triglycerides in the blood)
  5. Jaundice - yellow skin (a yellowish pigmentation of the skin)
1 - 2 years:
  1. Muscle aches (muscle pain)
  2. Dysstasia (difficulty in standing)
  3. Head injury
  4. Headache (pain in head)
  5. Alanine aminotransferase increased
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Heart attack
  2. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  3. Nausea (feeling of having an urge to vomit)
  4. Type 2 diabetes
  5. Pain

Top conditions involved for these people *:

  1. Diabetes : 14 people, 8.97%
  2. Depression : 13 people, 8.33%
  3. High Blood Pressure : 10 people, 6.41%
  4. Bipolar Disorder (mood disorder): 9 people, 5.77%
  5. Hiv Infection : 9 people, 5.77%

Top co-used drugs for these people *:

  1. Zetia (24 people, 15.38%)
  2. Seroquel (22 people, 14.10%)
  3. Aspirin (19 people, 12.18%)
  4. Niaspan (19 people, 12.18%)
  5. Plavix (17 people, 10.90%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!